MRD / Regn No. : 20240000137 Date : 21/07/2026
Patient Name : Abdul Rashid Naskar Age & Gender : 72 Yrs. / Male
Contact No. : 7003312201 UHID :
Ht / Wt / BMI : 161 / 56.8 / 21.91 BP S / BP D : 140 / 75
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (21/Feb/2023) |
Subjective : DIAGNOSED DM 1 YEAR
Objective : NONE
Analysis : TYPE 2 DM,INCREASED FIB4 / NAFLD SCORE,THROMBOCYTOPENIA,S3F0 MASLD
Plan : CHANGE TO DPP4I SGLT2I,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : BUN BLOOD UREA NITROGEN: 22 mg/dL | CREATININE: 1.1 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 70.11 mL/min/1.73m2 | URIC ACID: 5.8 | BICARBONATE: 28 meq/L | CHLORIDE: 104 meq/L | POTASSIUM: 3.8 meQ/L | SODIUM: 143 meq/L | HDL HIGH DENSITY LIPOPROTEIN: 41 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 83 mg/dL | TGL TRIGLYCERIDE: 71 mg/dL | TOTAL CHOLESTEROL: 140 mg/dl | ALKALINE PHOSPHOTASE: 91 IU/L | DIRECT BILIRUBIN: 0.2 mg/dl | SGOT (AST): 21 U/L | SGPT (ALT): 19 IU/L | TOTAL BILIRUBIN: 0.4 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.6 % | TSH : 2.6 mIU/L | VITAMIN D (25 OH): 38.8 ng/mL | HEMOGLOBIN: 13.3 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 85.6 fL | WBC WHITE BLOOD CELLS: 591 K/uL
S# Generic (Trade) Name Route Dosage Usage Duration
1 EMPAGLIFLOZIN 10 MG LINAGLIPTIN 5 MG
GLYXAMBI 10/5
1-0-0 BEFORE FOOD
TILL NEXT VISIT
EMPAGLIFLOZIN MAY CAUSE GENITOURINARY INFECTION KEEP GENITAL AREA CLEAN
       
Refill : 0 / Substitution:    
Education :
Next Visit : 20/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP BUN CR URINE MICROALBUMIN
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: